HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 167 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,528 | +0.4% | 40,000 | -5.2% | 0.01% | +16.7% |
| Q2 2023 | $1,522 | -56.0% | 42,200 | -53.4% | 0.01% | +20.0% |
| Q1 2023 | $3,459 | +129.5% | 90,600 | +241.9% | 0.01% | -28.6% |
| Q4 2022 | $1,507 | -99.9% | 26,500 | -39.8% | 0.01% | -12.5% |
| Q3 2022 | $1,739,000 | +48.6% | 44,000 | +65.4% | 0.01% | +60.0% |
| Q2 2022 | $1,170,000 | +30.4% | 26,600 | +18.2% | 0.01% | +66.7% |
| Q1 2022 | $897,000 | -56.6% | 22,500 | -56.2% | 0.00% | -57.1% |
| Q4 2021 | $2,066,000 | +3.9% | 51,400 | +5.1% | 0.01% | 0.0% |
| Q3 2021 | $1,989,000 | -10.4% | 48,900 | 0.0% | 0.01% | -12.5% |
| Q2 2021 | $2,220,000 | +206.2% | 48,900 | +181.0% | 0.01% | +166.7% |
| Q1 2021 | $725,000 | -6.7% | 17,400 | -4.4% | 0.00% | 0.0% |
| Q4 2020 | $777,000 | +79.4% | 18,200 | +10.3% | 0.00% | +50.0% |
| Q3 2020 | $433,000 | -5.5% | 16,500 | -3.5% | 0.00% | 0.0% |
| Q2 2020 | $458,000 | -3.8% | 17,100 | -35.5% | 0.00% | -33.3% |
| Q1 2020 | $476,000 | -59.2% | 26,500 | -59.8% | 0.00% | -40.0% |
| Q4 2019 | $1,168,000 | -46.3% | 65,900 | -53.0% | 0.01% | 0.0% |
| Q3 2019 | $2,174,000 | +80.6% | 140,200 | +100.0% | 0.01% | 0.0% |
| Q2 2019 | $1,204,000 | +12.2% | 70,100 | +5.1% | 0.01% | 0.0% |
| Q1 2019 | $1,073,000 | +10.1% | 66,700 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $975,000 | -18.1% | 66,700 | +1.7% | 0.01% | 0.0% |
| Q3 2018 | $1,191,000 | +7.7% | 65,600 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $1,106,000 | +1216.7% | 65,600 | +1425.6% | 0.01% | – |
| Q1 2018 | $84,000 | +10.5% | 4,300 | +13.2% | 0.00% | – |
| Q4 2017 | $76,000 | – | 3,800 | – | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q4 2015 | $105,000 | -41.0% | 6,100 | -54.1% | 0.00% | -100.0% |
| Q3 2015 | $178,000 | +36.9% | 13,300 | +129.3% | 0.00% | 0.0% |
| Q2 2015 | $130,000 | – | 5,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SNYDER CAPITAL MANAGEMENT L P | 4,324,232 | $165,185,662 | 3.73% |
| Steamboat Capital Partners, LLC | 196,898 | $7,521,504 | 2.79% |
| 2Xideas AG | 600,799 | $22,950,522 | 2.54% |
| BERNZOTT CAPITAL ADVISORS | 171,808 | $6,563,066 | 2.26% |
| Redwood Investments, LLC | 328,459 | $12,547,134 | 1.70% |
| Mesirow Institutional Investment Management, Inc. | 380,415 | $14,531,853 | 1.47% |
| Granite Investment Partners, LLC | 856,253 | $32,708,865 | 1.37% |
| Penn Capital Management Company, LLC | 324,707 | $12,453,211 | 1.28% |
| EFG Asset Management (North America) Corp. | 137,739 | $5,262,319 | 1.25% |
| First Light Asset Management, LLC | 313,536 | $11,977,075 | 1.14% |